Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts.

D'Souza CA, Kronstad JW, Taylor G, Warren R, Yuen M, Hu G, Jung WH, Sham A, Kidd SE, Tangen K, Lee N, Zeilmaker T, Sawkins J, McVicker G, Shah S, Gnerre S, Griggs A, Zeng Q, Bartlett K, Li W, Wang X, Heitman J, Stajich JE, Fraser JA, Meyer W, Carter D, Schein J, Krzywinski M, Kwon-Chung KJ, Varma A, Wang J, Brunham R, Fyfe M, Ouellette BF, Siddiqui A, Marra M, Jones S, Holt R, Birren BW, Galagan JE, Cuomo CA.

MBio. 2011 Feb 8;2(1):e00342-10. doi: 10.1128/mBio.00342-10. Print 2011.

2.

In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.

Chowdhary A, Randhawa HS, Sundar G, Kathuria S, Prakash A, Khan Z, Sun S, Xu J.

J Med Microbiol. 2011 Jul;60(Pt 7):961-7. doi: 10.1099/jmm.0.029025-0. Epub 2011 Mar 10.

PMID:
21393452
3.

Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.

Espinel-Ingroff A, Aller AI, Canton E, Castañón-Olivares LR, Chowdhary A, Cordoba S, Cuenca-Estrella M, Fothergill A, Fuller J, Govender N, Hagen F, Illnait-Zaragozi MT, Johnson E, Kidd S, Lass-Flörl C, Lockhart SR, Martins MA, Meis JF, Melhem MS, Ostrosky-Zeichner L, Pelaez T, Pfaller MA, Schell WA, St-Germain G, Trilles L, Turnidge J.

Antimicrob Agents Chemother. 2012 Nov;56(11):5898-906. doi: 10.1128/AAC.01115-12. Epub 2012 Sep 4.

4.

A decade of experience: Cryptococcus gattii in British Columbia.

Bartlett KH, Cheng PY, Duncan C, Galanis E, Hoang L, Kidd S, Lee MK, Lester S, MacDougall L, Mak S, Morshed M, Taylor M, Kronstad J.

Mycopathologia. 2012 Jun;173(5-6):311-9. doi: 10.1007/s11046-011-9475-x. Epub 2011 Sep 30.

PMID:
21960040
5.

Genome Evolution and Innovation across the Four Major Lineages of Cryptococcus gattii.

Farrer RA, Desjardins CA, Sakthikumar S, Gujja S, Saif S, Zeng Q, Chen Y, Voelz K, Heitman J, May RC, Fisher MC, Cuomo CA.

MBio. 2015 Sep 1;6(5):e00868-15. doi: 10.1128/mBio.00868-15.

6.

Calcineurin governs thermotolerance and virulence of Cryptococcus gattii.

Chen YL, Lehman VN, Lewit Y, Averette AF, Heitman J.

G3 (Bethesda). 2013 Mar;3(3):527-39. doi: 10.1534/g3.112.004242. Epub 2013 Mar 1.

7.

Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans/C. gattii species complex in Thailand.

Kaocharoen S, Ngamskulrungroj P, Firacative C, Trilles L, Piyabongkarn D, Banlunara W, Poonwan N, Chaiprasert A, Meyer W, Chindamporn A.

PLoS Negl Trop Dis. 2013 Jul 4;7(7):e2297. doi: 10.1371/journal.pntd.0002297. Print 2013.

8.

Cryptococcus gattii in the Age of Whole-Genome Sequencing.

Meyer W.

MBio. 2015 Nov 17;6(6):e01761-15. doi: 10.1128/mBio.01761-15.

9.

Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States.

Iqbal N, DeBess EE, Wohrle R, Sun B, Nett RJ, Ahlquist AM, Chiller T, Lockhart SR; Cryptococcus gattii Public Health Working Group..

J Clin Microbiol. 2010 Feb;48(2):539-44. doi: 10.1128/JCM.01505-09. Epub 2009 Dec 9.

10.

In vitro susceptibility of the yeast pathogen cryptococcus to fluconazole and other azoles varies with molecular genotype.

Chong HS, Dagg R, Malik R, Chen S, Carter D.

J Clin Microbiol. 2010 Nov;48(11):4115-20. doi: 10.1128/JCM.01271-10. Epub 2010 Sep 15.

11.

Heteroresistance of Cryptococcus gattii to fluconazole.

Varma A, Kwon-Chung KJ.

Antimicrob Agents Chemother. 2010 Jun;54(6):2303-11. doi: 10.1128/AAC.00153-10. Epub 2010 Apr 12.

12.

Cryptococcosis due to Cryptococcus gattii in Germany from 2004-2013.

Smith IM, Stephan C, Hogardt M, Klawe C, Tintelnot K, Rickerts V.

Int J Med Microbiol. 2015 Oct;305(7):719-23. doi: 10.1016/j.ijmm.2015.08.023. Epub 2015 Aug 21.

PMID:
26341329
13.

Global VGIIa isolates are of comparable virulence to the major fatal Cryptococcus gattii Vancouver Island outbreak genotype.

Ngamskulrungroj P, Serena C, Gilgado F, Malik R, Meyer W.

Clin Microbiol Infect. 2011 Feb;17(2):251-8. doi: 10.1111/j.1469-0691.2010.03222.x.

14.

Cryptococcus gattii comparative genomics and transcriptomics: a NIH/NIAID White Paper.

Chaturvedi V, Nierman WC.

Mycopathologia. 2012 Jun;173(5-6):367-73. doi: 10.1007/s11046-011-9512-9. Epub 2011 Dec 17. Review.

PMID:
22179781
15.
16.

Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.

Aminnejad M, Diaz M, Arabatzis M, Castañeda E, Lazera M, Velegraki A, Marriott D, Sorrell TC, Meyer W.

Mycopathologia. 2012 Jun;173(5-6):337-46. doi: 10.1007/s11046-011-9491-x. Epub 2011 Nov 13.

PMID:
22081254
17.

Susceptibility to antifungal agents and genotypes of Brazilian clinical and environmental Cryptococcus gattii strains.

Silva DC, Martins MA, Szeszs MW, Bonfietti LX, Matos D, Melhem MS.

Diagn Microbiol Infect Dis. 2012 Apr;72(4):332-9. doi: 10.1016/j.diagmicrobio.2011.11.016. Epub 2012 Feb 14.

PMID:
22341512
18.

Cryptococcus gattii infections.

Chen SC, Meyer W, Sorrell TC.

Clin Microbiol Rev. 2014 Oct;27(4):980-1024. doi: 10.1128/CMR.00126-13. Review.

19.

Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII) isolates from Southern Brazil.

Herkert PF, Hagen F, de Oliveira Salvador GL, Gomes RR, Ferreira MS, Vicente VA, Muro MD, Pinheiro RL, Meis JF, Queiroz-Telles F.

Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1803-1810. Epub 2016 Aug 1.

PMID:
27477855
20.

Primary cutaneous cryptococcosis in an immunocompetent patient due to Cryptococcus gattii molecular type VGI in Brazil: a case report and review of literature.

Nascimento E, Bonifácio da Silva ME, Martinez R, von Zeska Kress MR.

Mycoses. 2014 Jul;57(7):442-7. doi: 10.1111/myc.12176. Epub 2014 Feb 24.

PMID:
24612099

Supplemental Content

Support Center